These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23573551)

  • 1. Possible options for malaria chemoprophylaxis on the horizon.
    Shanks GD
    J Travel Med; 1999 May; 6 Suppl 1():S31-2. PubMed ID: 23573551
    [No Abstract]   [Full Text] [Related]  

  • 2. Practical therapeutics malaria chemoprophylaxis.
    Juma FD
    East Afr Med J; 1984 Mar; 61(3):254-9. PubMed ID: 6383777
    [No Abstract]   [Full Text] [Related]  

  • 3. Malaria chemoprophylaxis in the age of drug resistance. II. Drugs that may be available in the future.
    Shanks GD; Kain KC; Keystone JS
    Clin Infect Dis; 2001 Aug; 33(3):381-5. PubMed ID: 11438908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost considerations of malaria chemoprophylaxis including use of primaquine for primary or terminal chemoprophylaxis.
    Bryan JP
    Am J Trop Med Hyg; 2006 Sep; 75(3):416-20. PubMed ID: 16968914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving compliance with malaria chemoprophylaxis in Afghanistan.
    Brisson P; Woll M; Brisson M
    Mil Med; 2012 Dec; 177(12):1539-42. PubMed ID: 23397702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primaquine as prophylaxis for malaria for nonimmune travelers: A comparison with mefloquine and doxycycline.
    Schwartz E; Regev-Yochay G
    Clin Infect Dis; 1999 Dec; 29(6):1502-6. PubMed ID: 10585803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational malaria chemoprophylaxis - The position of primaquine.
    Baird JK
    Travel Med Infect Dis; 2017; 17():3-4. PubMed ID: 28450186
    [No Abstract]   [Full Text] [Related]  

  • 8. Malaria prophylaxis/radical cure: recent experiences of the Australian Defence Force.
    Edstein MD; Walsh DS; Eamsila C; Sasiprapha T; Nasveld PE; Kitchener S; Rieckmann KH
    Med Trop (Mars); 2001; 61(1):56-8. PubMed ID: 11584657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of artemether-azithromycin versus artemether-doxycycline in the treatment of multiple drug resistant falciparum malaria.
    Na-Bangchang K; Kanda T; Tipawangso P; Thanavibul A; Suprakob K; Ibrahim M; Wattanagoon Y; Karbwang J
    Southeast Asian J Trop Med Public Health; 1996 Sep; 27(3):522-5. PubMed ID: 9185262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to malaria prophylaxis among travelers from a middle-income country.
    Rodrigues KMP; Costa ABFD; Santoro-Lopes G
    Rev Soc Bras Med Trop; 2019 Jun; 52():e20190014. PubMed ID: 31188918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review: Improving the therapeutic index of 8-aminoquinolines by the use of drug combinations: review of the literature and proposal for future investigations.
    Myint HY; Berman J; Walker L; Pybus B; Melendez V; Baird JK; Ohrt C
    Am J Trop Med Hyg; 2011 Dec; 85(6):1010-4. PubMed ID: 22144436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical inquiries. When should travelers begin malaria prophylaxis?
    Clark SL; Crawford P; Nichols W; Reamy BV
    J Fam Pract; 2007 Nov; 56(11):950-2. PubMed ID: 17976346
    [No Abstract]   [Full Text] [Related]  

  • 13. Malaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regimens.
    Kain KC; Shanks GD; Keystone JS
    Clin Infect Dis; 2001 Jul; 33(2):226-34. PubMed ID: 11418883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of malaria].
    Botella de Maglia J; Espacio Casanovas A
    Rev Clin Esp; 1999 Aug; 199(8):549-50. PubMed ID: 10522443
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chemoprophylaxis of malaria in travelers to endemic zones].
    de Górgolas Hernández-Mora M; Blanco García A; Martín Torres MP; Fernández Guerrero ML
    Rev Clin Esp; 1998 Jun; 198(6):364-8. PubMed ID: 9691743
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of adherence to malaria chemoprophylaxis in a French Navy frigate deployed in Southeast Asia.
    Nicolas B; Papillault des Charbonnières L; Vasseur T; Mauclere P
    Med Sante Trop; 2017 Jun; 27(2):155-159. PubMed ID: 28572077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malaria chemoprophylaxis' compliance in travelers.
    Bocci G; Troiano G; Golinelli D; Verzuri A; Rossi S; Nante N
    Ann Ig; 2018; 30(1):71-72. PubMed ID: 29215134
    [No Abstract]   [Full Text] [Related]  

  • 18. Inadequate chemoprophylaxis and the risk of malaria.
    Massey P; Durrheim DN; Speare R
    Aust Fam Physician; 2007 Dec; 36(12):1058-60. PubMed ID: 18075636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compliance with antimalarial chemoprophylaxis recommendations for wounded United States military personnel admitted to a military treatment facility.
    Rini EA; Weintrob AC; Tribble DR; Lloyd BA; Warkentien TE; Shaikh F; Li P; Aggarwal D; Carson ML; Murray CK;
    Am J Trop Med Hyg; 2014 Jun; 90(6):1113-6. PubMed ID: 24732457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azithromycin: antimalarial profile against blood- and sporozoite-induced infections in mice and monkeys.
    Puri SK; Singh N
    Exp Parasitol; 2000 Jan; 94(1):8-14. PubMed ID: 10631075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.